Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
hydroxyethyl starch (voluven) (1 trial)
sodium chloride (2 trials)
pamrevlumab (1 trial)
sodium bicarbonate (1 trial)
selenocysteine (1 trial)
selenomethionine se-75 (1 trial)
vadimezan (1 trial)
albuterol (proventil) (1 trial)
Acute Kidney Injury (Phase 2)
Fibrosis (Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 2)
Pulmonary Fibrosis (Phase 2)
Trials (6 total)
Trial APIs (8 total)